Usana Health Sciences (USNA) Receivables - Other (2016 - 2026)
Usana Health Sciences (USNA) has disclosed Receivables - Other for 11 consecutive years, with $7.4 million as the latest value for Q4 2024.
- On a quarterly basis, Receivables - Other changed N/A to $7.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $7.4 million, a N/A change, with the full-year FY2024 number at $7.4 million, changed N/A from a year prior.
- Receivables - Other was $7.4 million for Q4 2024 at Usana Health Sciences, up from $5.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $7.4 million in Q4 2024 to a low of $5.2 million in Q4 2022.
- A 3-year average of $6.1 million and a median of $5.9 million in 2021 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: decreased 6.96% in 2021, then dropped 10.68% in 2022.
- Usana Health Sciences' Receivables - Other stood at $6.3 million in 2021, then fell by 17.1% to $5.2 million in 2022, then skyrocketed by 43.14% to $7.4 million in 2024.
- Per Business Quant, the three most recent readings for USNA's Receivables - Other are $7.4 million (Q4 2024), $5.2 million (Q4 2022), and $5.6 million (Q1 2022).